These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 18500170)

  • 1. Differential expression of RUNX genes in human esophageal squamous cell carcinoma: downregulation of RUNX3 worsens patient prognosis.
    Tonomoto Y; Tachibana M; Dhar DK; Onoda T; Hata K; Ohnuma H; Tanaka T; Nagasue N
    Oncology; 2007; 73(5-6):346-56. PubMed ID: 18500170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased expression of RUNX3 is correlated with tumor progression and poor prognosis in patients with esophageal squamous cell carcinoma.
    Sugiura H; Ishiguro H; Kuwabara Y; Kimura M; Mitsui A; Mori Y; Ogawa R; Katada T; Harata K; Fujii Y
    Oncol Rep; 2008 Mar; 19(3):713-9. PubMed ID: 18288406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Promoter hypermethylation of the RUNX3 gene in esophageal squamous cell carcinoma.
    Long C; Yin B; Lu Q; Zhou X; Hu J; Yang Y; Yu F; Yuan Y
    Cancer Invest; 2007 Dec; 25(8):685-90. PubMed ID: 18058463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of RUNX3 gene, methylation status and clinicopathological significance in breast cancer and breast cancer cell lines.
    Jiang Y; Tong D; Lou G; Zhang Y; Geng J
    Pathobiology; 2008; 75(4):244-51. PubMed ID: 18580070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequent silencing of RUNX3 in esophageal squamous cell carcinomas is associated with radioresistance and poor prognosis.
    Sakakura C; Miyagawa K; Fukuda KI; Nakashima S; Yoshikawa T; Kin S; Nakase Y; Ida H; Yazumi S; Yamagishi H; Okanoue T; Chiba T; Ito K; Hagiwara A; Ito Y
    Oncogene; 2007 Aug; 26(40):5927-38. PubMed ID: 17384682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Promoter hypermethylation of RASSF1A and RUNX3 genes as an independent prognostic prediction marker in surgically resected non-small cell lung cancers.
    Yanagawa N; Tamura G; Oizumi H; Kanauchi N; Endoh M; Sadahiro M; Motoyama T
    Lung Cancer; 2007 Oct; 58(1):131-8. PubMed ID: 17606310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methylation of the RUNX3 promoter as a potential prognostic marker for bladder tumor.
    Kim EJ; Kim YJ; Jeong P; Ha YS; Bae SC; Kim WJ
    J Urol; 2008 Sep; 180(3):1141-5. PubMed ID: 18639281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequent hemizygous deletion at 1p36 and hypermethylation downregulate RUNX3 expression in human lung cancer cell lines.
    Yanada M; Yaoi T; Shimada J; Sakakura C; Nishimura M; Ito K; Terauchi K; Nishiyama K; Itoh K; Fushiki S
    Oncol Rep; 2005 Oct; 14(4):817-22. PubMed ID: 16142337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Relationship between hypermethylation of Runx3 gene and the development and metastasis of laryngeal carcinoma].
    Tang J; Bai W; Ji W; Gao H; Liu J
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2010 Sep; 24(18):834-7. PubMed ID: 21254652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of the RUNX3 gene methylation in serum DNA from esophagus squamous cell carcinoma, gastric and colorectal adenocarcinoma patients.
    Zheng Y; Zhang Y; Huang X; Chen L
    Hepatogastroenterology; 2011; 58(112):2007-11. PubMed ID: 22234069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The distinct role of the Runx proteins in chondrocyte differentiation and intervertebral disc degeneration: findings in murine models and in human disease.
    Sato S; Kimura A; Ozdemir J; Asou Y; Miyazaki M; Jinno T; Ae K; Liu X; Osaki M; Takeuchi Y; Fukumoto S; Kawaguchi H; Haro H; Shinomiya K; Karsenty G; Takeda S
    Arthritis Rheum; 2008 Sep; 58(9):2764-75. PubMed ID: 18759297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypermethylation of RUNX3 but not WIF1 gene and its association with stage and nodal status of tongue cancers.
    Supic G; Kozomara R; Jovic N; Zeljic K; Magic Z
    Oral Dis; 2011 Nov; 17(8):794-800. PubMed ID: 21819494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequent inactivation of RUNX3 in endometrial carcinoma.
    Yoshizaki T; Enomoto T; Fujita M; Ueda Y; Miyatake T; Fujiwara K; Miyake T; Kimura T; Yoshino K; Kimura T
    Gynecol Oncol; 2008 Sep; 110(3):439-44. PubMed ID: 18572225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of RUNX3 protein in human esophageal mucosa and squamous cell carcinoma.
    Hiramatsu T; Osaki M; Ito Y; Tanji Y; Tokuyasu N; Ito H
    Pathobiology; 2005; 72(6):316-24. PubMed ID: 16582583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RUNX3 methylation as a predictor for disease progression in patients with non-muscle-invasive bladder cancer.
    Yan C; Kim YW; Ha YS; Kim IY; Kim YJ; Yun SJ; Moon SK; Bae SC; Kim WJ
    J Surg Oncol; 2012 Mar; 105(4):425-30. PubMed ID: 22311819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and prognostic significance of EFNB2 and EphB4 genes in patients with oesophageal squamous cell carcinoma.
    Tachibana M; Tonomoto Y; Hyakudomi R; Hyakudomi M; Hattori S; Ueda S; Kinugasa S; Yoshimura H
    Dig Liver Dis; 2007 Aug; 39(8):725-32. PubMed ID: 17611172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression status of RUNX1/AML1 in normal gastric epithelium and its mutational analysis in microdissected gastric cancer cells.
    Usui T; Aoyagi K; Saeki N; Nakanishi Y; Kanai Y; Ohki M; Ogawa K; Yoshida T; Sasaki H
    Int J Oncol; 2006 Oct; 29(4):779-84. PubMed ID: 16964375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RUNX3 inactivation by frequent promoter hypermethylation and protein mislocalization constitute an early event in breast cancer progression.
    Subramaniam MM; Chan JY; Soong R; Ito K; Ito Y; Yeoh KG; Salto-Tellez M; Putti TC
    Breast Cancer Res Treat; 2009 Jan; 113(1):113-21. PubMed ID: 18256927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of fragile histidine triad gene expression is associated with progression of esophageal squamous cell carcinoma, but not with the patient's prognosis and smoking history.
    Shimada Y; Sato F; Watanabe G; Yamasaki S; Kato M; Maeda M; Imamura M
    Cancer; 2000 Jul; 89(1):5-11. PubMed ID: 10896994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The overexpression of caveolin-1 and caveolin-2 correlates with a poor prognosis and tumor progression in esophageal squamous cell carcinoma.
    Ando T; Ishiguro H; Kimura M; Mitsui A; Mori Y; Sugito N; Tomoda K; Mori R; Harada K; Katada T; Ogawa R; Fujii Y; Kuwabara Y
    Oncol Rep; 2007 Sep; 18(3):601-9. PubMed ID: 17671707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.